Laura Barreyro

2.2k total citations
19 papers, 855 citations indexed

About

Laura Barreyro is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Laura Barreyro has authored 19 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 10 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Laura Barreyro's work include Acute Myeloid Leukemia Research (14 papers), Immune cells in cancer (5 papers) and Ubiquitin and proteasome pathways (3 papers). Laura Barreyro is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Immune cells in cancer (5 papers) and Ubiquitin and proteasome pathways (3 papers). Laura Barreyro collaborates with scholars based in United States, United Kingdom and India. Laura Barreyro's co-authors include Daniel T. Starczynowski, Ulrich Steidl, Timothy M. Chlon, Britta Will, Boris Bartholdy, Michael Roth, Ashley Pandolfi, Amit Verma, Tihomira I. Todorova and Tushar D. Bhagat and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Laura Barreyro

18 papers receiving 850 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Barreyro United States 12 512 375 301 154 127 19 855
Tara MacRae Canada 14 374 0.7× 466 1.2× 159 0.5× 123 0.8× 118 0.9× 25 735
R Delwel Netherlands 13 609 1.2× 549 1.5× 235 0.8× 140 0.9× 172 1.4× 17 994
Allison L. Boyd Canada 11 360 0.7× 312 0.8× 148 0.5× 107 0.7× 123 1.0× 19 640
Siamak Jabbarzadeh‐Tabrizi Japan 10 247 0.5× 314 0.8× 252 0.8× 99 0.6× 172 1.4× 13 652
Brooke Snetsinger Canada 8 242 0.5× 287 0.8× 175 0.6× 141 0.9× 104 0.8× 18 664
Shaoyan Hu China 17 209 0.4× 428 1.1× 150 0.5× 60 0.4× 103 0.8× 76 715
Lisa Patrone United States 12 596 1.2× 242 0.6× 293 1.0× 189 1.2× 109 0.9× 14 1.0k
Chung Hoow Kok Australia 17 454 0.9× 338 0.9× 116 0.4× 245 1.6× 153 1.2× 68 800
Theodore M. Duffy United States 12 206 0.4× 177 0.5× 244 0.8× 125 0.8× 119 0.9× 24 623

Countries citing papers authored by Laura Barreyro

Since Specialization
Citations

This map shows the geographic impact of Laura Barreyro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Barreyro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Barreyro more than expected).

Fields of papers citing papers by Laura Barreyro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Barreyro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Barreyro. The network helps show where Laura Barreyro may publish in the future.

Co-authorship network of co-authors of Laura Barreyro

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Barreyro. A scholar is included among the top collaborators of Laura Barreyro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Barreyro. Laura Barreyro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Barreyro, Laura, Kathleen Hueneman, Issac Choi, et al.. (2025). Ubiquitin-conjugating enzyme UBE2N modulates proteostasis in immunoproteasome-positive acute myeloid leukemia. Journal of Clinical Investigation. 135(10). 4 indexed citations
2.
Barreyro, Laura, Kathleen Hueneman, Michael A. Wyder, et al.. (2024). Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AML. iScience. 27(6). 109809–109809. 7 indexed citations
3.
Varshavsky, Asya, Alexander W. Macfarlane, Laura Barreyro, et al.. (2022). Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Venetoclax or Intensive Chemotherapy on Their Biology. Cancers. 14(14). 3352–3352. 11 indexed citations
4.
Barreyro, Laura, Kathleen Hueneman, Kwangmin Choi, et al.. (2022). UBE2N Is a Druggable Target and an Essential Ubiquitin-Conjugating Enzyme in Myeloid Malignancies. Blood. 140(Supplement 1). 5830–5830. 1 indexed citations
5.
Barreyro, Laura, Timothy M. Chlon, & Daniel T. Starczynowski. (2018). Chronic immune response dysregulation in MDS pathogenesis. Blood. 132(15). 1553–1560. 158 indexed citations
6.
Mitchell, Kelly, Laura Barreyro, Tihomira I. Todorova, et al.. (2018). IL1RAP potentiates multiple oncogenic signaling pathways in AML. The Journal of Experimental Medicine. 215(6). 1709–1727. 60 indexed citations
7.
Barreyro, Laura, Lyndsey Bolanos, Mario Pujato, et al.. (2016). Inhibition of UBE2N As a Therapeutic Approach in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML). Blood. 128(22). 579–579. 2 indexed citations
8.
Schinke, Carolina, Orsi Giricz, Weijuan Li, et al.. (2015). IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 125(20). 3144–3152. 145 indexed citations
9.
Varney, Melinda E., et al.. (2015). Deconstructing innate immune signaling in myelodysplastic syndromes. Experimental Hematology. 43(8). 587–598. 31 indexed citations
10.
Will, Britta, Thomas O. Vogler, Boris Bartholdy, et al.. (2015). Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia. Nature Medicine. 21(10). 1172–1181. 81 indexed citations
11.
Will, Britta, Thomas O. Vogler, Boris Bartholdy, et al.. (2015). Minimal Reduction of PU.1 Is Sufficient to Induce a Preleukemic State and Promote Development of Acute Myeloid Leukemia. Blood. 126(23). 305–305.
12.
Bartholdy, Boris, Maximilian Christopeit, Britta Will, et al.. (2014). HSC commitment–associated epigenetic signature is prognostic in acute myeloid leukemia. Journal of Clinical Investigation. 124(3). 1158–1167. 32 indexed citations
13.
Shastri, Aditi, Carolina Schinke, Tushar D. Bhagat, et al.. (2014). Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine. Blood. 124(21). 3602–3602. 6 indexed citations
14.
Will, Britta, Thomas O. Vogler, Boris Bartholdy, et al.. (2013). Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitment. Nature Immunology. 14(5). 437–445. 83 indexed citations
15.
Pandolfi, Ashley, Laura Barreyro, & Ulrich Steidl. (2013). Concise Review: Preleukemic Stem Cells: Molecular Biology and Clinical Implications of the Precursors to Leukemia Stem Cells. Stem Cells Translational Medicine. 2(2). 143–150. 48 indexed citations
16.
Schinke, Carolina, Orsi Giricz, Shanisha Gordon, et al.. (2013). Inhibition Of CXCR2 As a Therapeutic Strategy In AML and MDS. Blood. 122(21). 484–484. 2 indexed citations
17.
Kawahara, Masahiro, Ashley Pandolfi, Boris Bartholdy, et al.. (2012). H2.0-like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia. Cancer Cell. 22(2). 194–208. 33 indexed citations
18.
Roth, Michael, Britta Will, Laura Barreyro, et al.. (2012). Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. Blood. 120(2). 386–394. 119 indexed citations
19.
Wang, Hao, et al.. (2011). Molecular Determinants and Thermodynamics of the Amyloid Precursor Protein Transmembrane Domain Implicated in Alzheimer's Disease. Journal of Molecular Biology. 408(5). 879–895. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tara MacRae Breakdown of academic impact, for papers by R Delwel Breakdown of academic impact, for papers by Allison L. Boyd Breakdown of academic impact, for papers by Siamak Jabbarzadeh‐Tabrizi Breakdown of academic impact, for papers by Brooke Snetsinger Breakdown of academic impact, for papers by Shaoyan Hu Breakdown of academic impact, for papers by Lisa Patrone Breakdown of academic impact, for papers by Chung Hoow Kok Breakdown of academic impact, for papers by Theodore M. Duffy
Rankless by CCL
2026